N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide (BioDeep_00000174175)

   

human metabolite blood metabolite


代谢物信息卡片


N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulphanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide

化学式: C17H24N4O2S2 (380.13406039999995)
中文名称: N-[5-[(5-叔丁基-1,3-恶唑-2-基)甲硫基]-1,3-噻唑-2-基]哌啶-4-甲酰胺
谱图信息: 最多检出来源 Homo sapiens(blood) 88.89%

分子结构信息

SMILES: CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1
InChI: InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)

描述信息

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

同义名列表

8 个代谢物同义名

N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulphanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide; N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide; N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide; SNS-032 (BMS-387032); BMS 387032; BMS-387032; SNS 032; SNS-032



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Liu Yang, Dongdong Fang, Huijun Chen, Yiyu Lu, Zheng Dong, Han-Fei Ding, Qing Jing, Shi-Bing Su, Shuang Huang. Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression. Oncotarget. 2015 Aug; 6(25):20801-12. doi: 10.18632/oncotarget.4600. [PMID: 26204491]
  • Daniela Cihalova, Frantisek Staud, Martina Ceckova. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. Cancer chemotherapy and pharmacology. 2015 Jul; 76(1):105-16. doi: 10.1007/s00280-015-2772-1. [PMID: 25986678]
  • Rong Chen, Lei Guo, Yuling Chen, Yingjun Jiang, William G Wierda, William Plunkett. Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia. Blood. 2011 Jan; 117(1):156-64. doi: 10.1182/blood-2010-01-262808. [PMID: 20971952]
  • Andrew Conroy, David E Stockett, Duncan Walker, Michelle R Arkin, Ute Hoch, Judith A Fox, Rachael Elizabeth Hawtin. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples. Cancer chemotherapy and pharmacology. 2009 Sep; 64(4):723-32. doi: 10.1007/s00280-008-0921-5. [PMID: 19169685]
  • Elisabeth I Heath, Keith Bible, Robert E Martell, Daniel C Adelman, Patricia M Lorusso. A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Investigational new drugs. 2008 Feb; 26(1):59-65. doi: 10.1007/s10637-007-9090-3. [PMID: 17938863]
  • Amrita V Kamath, Saeho Chong, Ming Chang, Punit H Marathe. P-glycoprotein plays a role in the oral absorption of BMS-387032, a potent cyclin-dependent kinase 2 inhibitor, in rats. Cancer chemotherapy and pharmacology. 2005 Feb; 55(2):110-6. doi: 10.1007/s00280-004-0873-3. [PMID: 15338193]
  • Raj N Misra, Hai-yun Xiao, Kyoung S Kim, Songfeng Lu, Wen-Ching Han, Stephanie A Barbosa, John T Hunt, David B Rawlins, Weifang Shan, Syed Z Ahmed, Ligang Qian, Bang-Chi Chen, Rulin Zhao, Mark S Bednarz, Kristen A Kellar, Janet G Mulheron, Roberta Batorsky, Urvashi Roongta, Amrita Kamath, Punit Marathe, Sunanda A Ranadive, John S Sack, John S Tokarski, Nikola P Pavletich, Francis Y F Lee, Kevin R Webster, S David Kimball. N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. Journal of medicinal chemistry. 2004 Mar; 47(7):1719-28. doi: 10.1021/jm0305568. [PMID: 15027863]